162 related articles for article (PubMed ID: 8915880)
1. Presentation of the hydrophilic domains of hepatitis C viral E2 envelope glycoprotein on hepatitis B surface antigen particles.
Lee IH; Kim CH; Ryu WS
J Med Virol; 1996 Oct; 50(2):145-51. PubMed ID: 8915880
[TBL] [Abstract][Full Text] [Related]
2. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of hepatitis C Virus E2 glycoprotein fused to hepatitis B virus preS1(21-47) fragment in CHO cells.
Wang CL; Zhu LX; Liu J; Zhang ZC; Wang Y; Li GD
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):400-4. PubMed ID: 12098759
[TBL] [Abstract][Full Text] [Related]
5. Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies.
Patient R; Hourioux C; Vaudin P; Pagès JC; Roingeard P
N Biotechnol; 2009 Apr; 25(4):226-34. PubMed ID: 19356608
[TBL] [Abstract][Full Text] [Related]
6. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization.
Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M
Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876
[TBL] [Abstract][Full Text] [Related]
7. A unique amino acid substitution, L215Q, in the hepatitis B virus small envelope protein of a genotype F isolate that inhibits secretion of hepatitis B virus subviral particles.
Araujo NM; Vianna CO; Soares CC; Gomes SA
Intervirology; 2008; 51(2):81-6. PubMed ID: 18434744
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins.
Shaw ML; McLauchlan J; Mills PR; Patel AH; McCruden EA
J Med Virol; 2003 Jul; 70(3):361-72. PubMed ID: 12766998
[TBL] [Abstract][Full Text] [Related]
9. Delivery of a foreign epitope by sharing amino acid residues with the carrier matrix.
Cheong WS; Drummer HE; Netter HJ
J Virol Methods; 2009 Jun; 158(1-2):35-40. PubMed ID: 19189849
[TBL] [Abstract][Full Text] [Related]
10. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.
Slater-Handshy T; Droll DA; Fan X; Di Bisceglie AM; Chambers TJ
Virology; 2004 Feb; 319(1):36-48. PubMed ID: 14967486
[TBL] [Abstract][Full Text] [Related]
11. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
12. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes.
Bartosch B; Bukh J; Meunier JC; Granier C; Engle RE; Blackwelder WC; Emerson SU; Cosset FL; Purcell RH
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14199-204. PubMed ID: 14617769
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
Blanchet M; Sureau C
J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
[TBL] [Abstract][Full Text] [Related]
14. Morphological identification of hepatitis C virus E1 and E2 envelope glycoproteins on the virion surface using immunogold electron microscopy.
Kaito M; Watanabe S; Tanaka H; Fujita N; Konishi M; Iwasa M; Kobayashi Y; Gabazza EC; Adachi Y; Tsukiyama-Kohara K; Kohara M
Int J Mol Med; 2006 Oct; 18(4):673-8. PubMed ID: 16964422
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus Dane particles bind to human plasma apolipoprotein H.
Stefas I; Rucheton M; D'Angeac AD; Morel-Baccard C; Seigneurin JM; Zarski JP; Martin M; Cerutti M; Bossy JP; Missé D; Graafland H; Veas F
Hepatology; 2001 Jan; 33(1):207-17. PubMed ID: 11124838
[TBL] [Abstract][Full Text] [Related]
16. Expression and purification of Dengue virus type 2 envelope protein as a fusion with hepatitis B surface antigen in Pichia pastoris.
Bisht H; Chugh DA; Swaminathan S; Khanna N
Protein Expr Purif; 2001 Oct; 23(1):84-96. PubMed ID: 11570849
[TBL] [Abstract][Full Text] [Related]
17. Expression of HCV envelope proteins and the serological utility of the anti-E2 immune response.
Lesniewski RR; Watanabe S; Devare SG
Princess Takamatsu Symp; 1995; 25():129-37. PubMed ID: 8875617
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a structural protein of hepatitis B virus: a polymerase and surface fusion protein encoded by a spliced RNA.
Huang HL; Jeng KS; Hu CP; Tsai CH; Lo SJ; Chang C
Virology; 2000 Sep; 275(2):398-410. PubMed ID: 10998339
[TBL] [Abstract][Full Text] [Related]
19. Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.
Netter HJ; Macnaughton TB; Woo WP; Tindle R; Gowans EJ
J Virol; 2001 Mar; 75(5):2130-41. PubMed ID: 11160717
[TBL] [Abstract][Full Text] [Related]
20. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus.
Jenna S; Sureau C
Virology; 1998 Nov; 251(1):176-86. PubMed ID: 9813213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
